Welcome to the OMA Blog
The Obesity Medicine Association Blog is the leading industry hub for obesity medicine. Find the latest research, expert insights, and practical tips to tackle the multifaceted disease of obesity. Hear from OMA Outreach Committee members, OMA Board members, and more to gain a deeper understanding of the complex factors influencing obesity and explore innovative approaches to prevention, treatment, and long-term management. Join a community of healthcare professionals, researchers, and individuals passionate about combating obesity.
View by Category
Obesity Medications
Anti-obesity medications are a class of medications that have a primary indication for the treatment of obesity. Obesity is a multi-factorial chronic disease and like other…
OMA Member Robert Huster, MD, FACOG, Visits Capitol Hill
On Feb. 3, Robert Huster, MD, FACOG, a member of the Obesity Medicine Association’s advocacy committee, visited with congressional health care staff in the offices…
Dr. Craig Primack, OMA Vice President, Featured in Advances in Therapy
Craig Primack, MD, FACP, FAAP, FOMA, who is the vice president of the Obesity Medicine Association and a clinical obesity specialist in Scottsdale, Ariz., contributed…
2017 Obesity Guidelines Offer Tips for Patient-friendly Office Equipment
For millions of Americans battling obesity, the biggest obstacle to weight loss and wellness is not whether they can stick to a diet or exercise…
Topics of Interest from the AMA House of Delegates Interim Meeting
Anti-HCG Position Statement Dr. Lazarus: During a presentation by the Council on Science and Public Health about compounded hormone preparations, I introduced a recommendation that “the AMA…
Obesity Medicine Association Applauds American Medical Association’s Decision to Adopt New Anti-HCG Policy
Policy States Use of HCG for Weight Loss Inappropriate Today the American Medical Association (AMA) passed policy that ensures patients with obesity will receive better…
The Treatment of Obesity – FDA Approves BELVIQ XR ER
On July 19, Eisai, Inc., and Arena Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) approved BELVIQ XR (lorcaserin HCl) CIV extended-release…
Obesity Medicine Education is Now Available Online
The Obesity Medicine Association’s top-rated obesity medicine education is now available online at the Obesity Medicine Academy! Watch presentations online and earn CME/CE credit from…
The 2016 Obesity Algorithm is Here!
The 2016 Obesity Algorithm is Here! Every year, leaders in the field of obesity medicine update the Obesity Algorithm® to reflect the changing landscape of…